The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Prognostic Factors in Non-small Cell Lung Cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Revisions in the International System for Staging Lung Cancer
Mountain, C. F. (1997) · Chest · doi:10.1378/chest.111.6.1710 · Cited by 4,565
Non-small Cell Lung Cancer Collaborative Group (1995) · BMJ · doi:10.1136/bmj.311.7010.899 · Cited by 2,850
Regional Lymph Node Classification for Lung Cancer Staging
Mountain, C. F., & Dresler, C. M. (1997) · Chest · doi:10.1378/chest.111.6.1718 · Cited by 1,439
Incidence of local recurrence and second primary tumors in resected stage I lung cancer
Martini, N., Bains, M. S., Burt, M. E., Zakowski, M. F., McCormack, P., Rusch, V. W., & Ginsberg, R. J. (1995) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(95)70427-2 · Cited by 973
Yódice, A., & CHIARE, F. L. (1954) · PubMed · Cited by 836
K-ras Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
Slebos, R. J. C., Kibbelaar, R. E., Dalesio, O., Kooistra, A., Stam, J., Meijer, C. J. L. M., Wagenaar, S. S., Vanderschueren, R. G. J. R. A., van Zandwijk, N., Mooi, W. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008303230902 · Cited by 809
Albain, K. S., Crowley, J. J., LeBlanc, M., & Livingston, R. B. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.9.1618 · Cited by 728
Buccheri, G., Ferrigno, D., & Tamburini, M. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00664-8 · Cited by 629
Cited by
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji237 · Cited by 2,162
REporting recommendations for tumour MARKer prognostic studies (REMARK).
for the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics, McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602678 · Cited by 1,394
“Such reporting deficiencies are increasingly being highlighted by systematic reviews of the published literature on particular markers or cancers [19–25].”
BackgroundReporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Altman, D. G., McShane, L. M., Sauerbrei, W., & Taube, S. E. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001216 · Cited by 1,013
The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends
Youlden, D. R., Cramb, S. M., & Baade, P. D. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31818020eb · Cited by 812
REporting recommendations for tumor MARKer prognostic studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9242-8 · Cited by 809
Reporting Recommendations for Tumor Marker Prognostic Studies
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.0454 · Cited by 779
Scagliotti, G., Hanna, N., Fossella, F., Sugarman, K., Blatter, J., Peterson, P., Simms, L., & Shepherd, F. A. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0232 · Cited by 690
A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer
Potti, A., Mukherjee, S., Petersen, R., Dressman, H. K., Bild, A., Koontz, J., Kratzke, R., Watson, M. A., Kelley, M., Ginsburg, G. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060467 · Cited by 576
RetractedThe 2004 World Health Organization classification of lung tumors
Beasley, M. B., Brambilla, E., & Travis, W. D. (2005) · Seminars in Roentgenology · doi:10.1053/j.ro.2005.01.001 · Cited by 564
REporting recommendations for tumor MARKer prognostic studies (REMARK)
for the Statistics Subcommittee of the NCI—EORTC Working Group on Cancer Diagnostics (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0252 · Cited by 561
Recurrence after surgery in patients with NSCLC.
Uramoto, H., & Tanaka, F. (2014) · PubMed · doi:10.3978/j.issn.2218-6751.2013.12.05 · Cited by 540
Non–Small Cell Lung Cancer: Dual-Modality PET/CT in Preoperative Staging
Antoch, G., Stattaus, J., Nemat, A. T., Marnitz, S., Beyer, T., Kuehl, H., Bockisch, A., Debatin, J. F., & Freudenberg, L. S. (2003) · Radiology · doi:10.1148/radiol.2292021598 · Cited by 540
Maione, P., Perrone, F., Gallo, C., Manzione, L., Piantedosi, F., Barbera, S., Cigolari, S., Rosetti, F., Piazza, E., Robbiati, S. F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.527 · Cited by 478
Chansky, K., Sculier, J.-P., Crowley, J. J., Giroux, D., Van Meerbeeck, J., & Goldstraw, P. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a7716e · Cited by 456
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
Altman, D. G., McShane, L. M., Sauerbrei, W., & Taube, S. E. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-51 · Cited by 372
Kawaguchi, T., Takada, M., Kubo, A., Matsumura, A., Fukai, S., Tamura, A., Saito, R., Maruyama, Y., Kawahara, M., & Ignatius Ou, S.-H. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d2dcd9 · Cited by 354
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
Gallardo, E., Navarro, A., Viñolas, N., Marrades, R. M., Diaz, T., Gel, B., Quera, A., Bandres, E., Garcia-Foncillas, J., Ramirez, J., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp219 · Cited by 342
Positron Emission Tomography (PET) in Oncology
Gallamini, A., Zwarthoed, C., & Borra, A. (2014) · Cancers · doi:10.3390/cancers6041821 · Cited by 312
REporting recommendations for tumour MARKer prognostic studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.03.032 · Cited by 311
Survival After Recurrent Nonsmall-Cell Lung Cancer After Complete Pulmonary Resection
Sugimura, H., Nichols, F. C., Yang, P., Allen, M. S., Cassivi, S. D., Deschamps, C., Williams, B. A., & Pairolero, P. C. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.08.046 · Cited by 293
Protein profiles associated with survival in lung adenocarcinoma
Chen, G., Gharib, T. G., Wang, H., Huang, C.-C., Kuick, R., Thomas, D. G., Shedden, K. A., Misek, D. E., Taylor, J. M. G., Giordano, T. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2233850100 · Cited by 277
Gautschi, O., Bigosch, C., Huegli, B., Jermann, M., Marx, A., Chassé, E., Ratschiller, D., Weder, W., Joerger, M., Betticher, D. C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.123 · Cited by 275
Hoang, T., Xu, R., Schiller, J. H., Bonomi, P., & Johnson, D. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.177 · Cited by 263
Sutani, A., Nagai, Y., Udagawa, K., Uchida, Y., Koyama, N., Murayama, Y., Tanaka, T., Miyazawa, H., Nagata, M., Kanazawa, M., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603466 · Cited by 167
“The latter three factors are well known as prognostic factors in NSCLC patients (Brundage et al, 2002).”
BackgroundMallett, S., Timmer, A., Sauerbrei, W., & Altman, D. G. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605462 · Cited by 122
Lee, P., Bazan, J. G., Lavori, P. W., Weerasuriya, D. K., Quon, A., Le, Q.-T., Wakelee, H. A., Graves, E. E., & Loo, B. W. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.05.001 · Cited by 92
Biomarkers in Lung Cancer: From Early Detection to Novel Therapeutics and Decision Making
Scott, A., & Salgia, R. (2008) · Biomarkers in Medicine · doi:10.2217/17520363.2.6.577 · Cited by 59
Metadata
- Authors
- Brundage, M. D., Davies, D., & Mackillop, W. J.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2002-09
- Volume
- 122
- Issue
- 3
- Pages
- 1037-1057
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2133040355
- Cited by
- 564
- References
- 128
- FWCI
- 21.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.